Prometheus Biosciences, Inc. Annual Nonoperating Income (Expense) in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Prometheus Biosciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to 2022.
  • Prometheus Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2023 was $7.83M, a 25993% increase year-over-year.
  • Prometheus Biosciences, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2023 was $11.8M.
  • Prometheus Biosciences, Inc. annual Nonoperating Income (Expense) for 2022 was $4.03M.
  • Prometheus Biosciences, Inc. annual Nonoperating Income (Expense) for 2021 was -$2.39M, a 12.2% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $4.03M +$6.42M Jan 1, 2022 Dec 31, 2022 10-K 2023-02-28
2021 -$2.39M -$260K -12.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 -$2.13M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.